Drug Profile
Celleks
Alternative Names: CelleksLatest Information Update: 30 Oct 2015
Price :
$50
*
At a glance
- Originator Pharm-Sintez
- Class
- Mechanism of Action Cell death inhibitors; Cell differentiation stimulants; Growth factor receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Cerebrovascular disorders; Haemorrhage